Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection.

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Journal	Clinical Medicine Insights: Women's Health
DOIs	https://doi.org/10.4137/CMWH.S10353
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

TY - JOUR

T1 - Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection.

AU - McConville, C

AU - Boyd, P

AU - Major, I

PY - 2014

Y1 - 2014

UR - http://europepmc.org/abstract/med/24741339

U2 - 10.4137/CMWH.S10353

DO - 10.4137/CMWH.S10353

M3 - Article

C2 - 24741339

JO - Clinical Medicine Insights: Women's Health

JF - Clinical Medicine Insights: Women's Health

ER -